Is palpitations a potential adverse effect of testosterone therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Palpitations Are Not a Documented Side Effect of Testosterone Therapy

Based on comprehensive guideline reviews and FDA labeling, palpitations are not listed as a recognized adverse effect of testosterone replacement therapy. The most authoritative sources on testosterone safety do not identify palpitations as a side effect 1, 2.

What the Evidence Shows

FDA-Approved Drug Label

The official FDA adverse reaction profile for intramuscular testosterone explicitly lists the following side effects 2:

  • Cardiovascular: Fluid retention (sodium, chloride, water retention)
  • Nervous system: Increased or decreased libido, headache, anxiety, depression, generalized paresthesia
  • Endocrine: Gynecomastia, excessive penile erections
  • Hematologic: Polycythemia, suppression of clotting factors
  • Other: Acne, hirsutism, injection site reactions

Palpitations are notably absent from this comprehensive list.

Guideline Evidence

The New England Journal of Medicine's comprehensive 2004 guideline on testosterone risks systematically reviewed all potential adverse effects and created detailed tables of risks 1. Their thorough assessment of cardiovascular risks focused on:

  • Coronary artery disease (no evidence of increased risk)
  • Lipid effects (neutral at physiologic doses)
  • Erythrocytosis (common, especially with injections)
  • Fluid retention (rarely clinically significant)

Palpitations were not mentioned as a cardiovascular or any other category of adverse effect.

Recent High-Quality Safety Data

The 2023 TRAVERSE trial—the largest randomized controlled trial of testosterone safety involving 5,246 men—specifically tracked cardiovascular events over 33 months 3. While the study documented atrial fibrillation as more common in the testosterone group, palpitations as a symptom were not reported as an adverse effect.

Clinical Context: What Could Explain Palpitations

If a patient on testosterone reports palpitations, consider these documented testosterone-related mechanisms:

  1. Erythrocytosis/Polycythemia 1:

    • Occurs in 3-18% with transdermal administration
    • Up to 44% with intramuscular injections
    • Increased blood viscosity could theoretically cause cardiovascular symptoms
    • Monitor hemoglobin/hematocrit regularly

  2. Atrial Fibrillation 3:

    • Higher incidence documented in TRAVERSE trial
    • This is an arrhythmia that would cause palpitations
    • Represents actual cardiac pathology, not a direct drug effect

  3. Fluid Retention 1, 2:

    • Can occur but rarely clinically significant
    • Could theoretically contribute to cardiovascular strain

Bottom Line

Palpitations are not an established side effect of testosterone therapy based on FDA labeling, comprehensive guidelines, and large-scale trials. If a patient experiences palpitations while on testosterone, investigate for:

  • Atrial fibrillation or other arrhythmias (obtain ECG)
  • Polycythemia (check CBC)
  • Alternative causes unrelated to testosterone

The symptom warrants evaluation but should not be automatically attributed to testosterone therapy itself.

References

3
Research

Cardiovascular Safety of Testosterone-Replacement Therapy.

The New England journal of medicine, 2023

Related Questions

What adverse effects are associated with taking high-dose testosterone?
A patient receiving 100 mg testosterone weekly has a serum testosterone level of 264 ng/dL; how should the testosterone regimen be adjusted?
Does testosterone replacement therapy increase gastric acid production in adult males?
In an adult male with low total testosterone and low free testosterone, what are the next steps in evaluation and management?
Do female-to-male transgender individuals require testosterone therapy for masculinization?
In a 17-year-old female using Yasmin (ethinyl estradiol 30 µg/drospirenone 3 mg) 28‑day combined oral contraceptive who experiences mid‑cycle breakthrough bleeding and fails to have withdrawal bleeding during the placebo week, what is the next best management step?
Summarize the complications of gastroduodenal ulcer and their surgical treatment options, including gastroduodenal procedures, for a general surgery exam.
In a patient with uveitis, axial spondyloarthritis, and Crohn’s disease who is HLA‑B27 negative, which genes could contribute to disease susceptibility?
Does a positive hepatitis B core antibody (anti‑HBc) and a positive hepatitis B surface antigen (HBsAg) indicate hepatitis B infection?
How should a poison ivy-induced allergic contact dermatitis be managed?
Can vitamin B12 deficiency or folate (folic acid) deficiency cause a decrease in neutrophil count?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question